Treatment decision making in metastatic prostate cancer (mPC).

Authors

Alicia Morgans

Alicia K. Morgans

Northwestern University, Chicago, IL

Alicia K. Morgans , Angela Fought , Benjamin Lee , David James VanderWeele , Maha H. A. Hussain , Kelvin A. Moses , David F. Penson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 224)

Abstract #

224

Poster Bd #

B2

Abstract Disclosures

Similar Posters

Poster

2016 Cancer Survivorship Symposium

Late-stage lung cancer patient preferences about chemotherapy treatment adverse side effects.

Late-stage lung cancer patient preferences about chemotherapy treatment adverse side effects.

First Author: K. M Islam

Poster

2024 ASCO Annual Meeting

Options for evaluating communication strategies in treatment and clinical trial discussions.

Options for evaluating communication strategies in treatment and clinical trial discussions.

First Author: Monica Arun Patel

First Author: Emre Dal